Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
QuintilesIMS
McKesson
Fuji
Colorcon
Deloitte
Chinese Patent Office
Cantor Fitzgerald

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MECLIZINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Meclizine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00641797 Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients Completed Lehigh Valley Hospital N/A Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.
NCT01443858 Meclizine as a Potential Smoking Cessation Treatment Completed Philip Morris USA, Inc. Phase 2 The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
NCT01443858 Meclizine as a Potential Smoking Cessation Treatment Completed Duke University Phase 2 The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
NCT01537471 The Effects of Antihistamines on Pre-Pulse Inhibition Completed Wallace H. Coulter Foundation Phase 1 The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.
NCT01537471 The Effects of Antihistamines on Pre-Pulse Inhibition Completed Duke University Phase 1 The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.
NCT02112578 Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin Recruiting Apsen Farmaceutica S.A. Phase 3 - Evaluation of the non inferiority of Meclin (meclizine) versus Dramin (Dimenhydrinate) to treat the symptoms of acute vertigo from peripheral origin after up to 4 weeks of treatment; - Evaluation of impact on quality of life in vertigo; - Compare the intensity of daytime sleepiness in the two treatment groups; - Compare the efficacy of drugs in relieving each of the 10 symptoms that make up the VS; - Compare the duration of treatment in both treatment groups; - Compare Adehence; - Compare the level of satisfaction from each group from the investigators and the subjects; - Adverse events;
NCT02625181 Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis Recruiting University of Washington N/A The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Meclizine Hydrochloride

Condition Name

Condition Name for Meclizine Hydrochloride
Intervention Trials
Benign Paroxysmal Positional Vertigo 1
Smoking Cessation 1
Postoperative Nausea and Vomiting 1
Nausea and Vomiting, Postoperative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Meclizine Hydrochloride
Intervention Trials
Dizziness 2
Vomiting 2
Postoperative Nausea and Vomiting 2
Nausea 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Meclizine Hydrochloride

Trials by Country

Trials by Country for Meclizine Hydrochloride
Location Trials
United States 5
Brazil 5
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Meclizine Hydrochloride
Location Trials
North Carolina 2
Texas 1
Tennessee 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Meclizine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Meclizine Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Meclizine Hydrochloride
Clinical Trial Phase Trials
Completed 3
Recruiting 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Meclizine Hydrochloride

Sponsor Name

Sponsor Name for Meclizine Hydrochloride
Sponsor Trials
Duke University 2
Philip Morris USA, Inc. 1
Yvonne Sada 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Meclizine Hydrochloride
Sponsor Trials
Other 9
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Teva
Johnson and Johnson
McKinsey
US Department of Justice
Express Scripts
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.